MUTATED HUMAN KIRSTEN RAS, DRIVEN BY A THYROGLOBULIN PROMOTER, INDUCES A GROWTH ADVANTAGE AND PARTIALLY DEDIFFERENTIATES RAT-THYROID EPITHELIAL-CELLS IN-VITRO
C. Monaco et al., MUTATED HUMAN KIRSTEN RAS, DRIVEN BY A THYROGLOBULIN PROMOTER, INDUCES A GROWTH ADVANTAGE AND PARTIALLY DEDIFFERENTIATES RAT-THYROID EPITHELIAL-CELLS IN-VITRO, International journal of cancer, 63(5), 1995, pp. 757-760
We have earlier shown that expression of the human activated Ki-ras, d
irected by the rat thyroglobulin CTG) promoter in the thyroid gland of
transgenic mice, is able to induce thyroid benign tumors, albeit at l
ow incidence. A likely explanation of our results is that the low leve
ls of exogenous Ki-ras transcripts are not sufficient to induce multif
ocal tumors in the thyroid gland. We have performed experiments to ana
lyze the effects of a similar construct in vitro upon thyroid-cell pro
liferation and differentiation. Transfection of FRTL-5 rat thyroid cel
ls with the human Ki-ras(val12) fused to the rat TG promoter is rapidl
y followed by reduced expression of the differentiation markers thyrog
lobulin, thyroperoxydase and thyrotropin receptor, but not by fully ma
lignant cell transformation. The data reported support the hypothesis
that Ki-ras mRNA levels are critical to the process of complete neopla
stic transformation of thyroid epithelial differentiated cells in vitr
o. (C) 1995 Wiley-Liss, Inc.